# Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes

> **NCT07145502** · — · ACTIVE_NOT_RECRUITING · sponsor: **Biocells Medical** · enrollment: 76 (actual)

## Conditions studied

- Autoimmune Encephalitis
- Early-stage Panencephalitis
- Neuroinflammatory Demyelination

## Interventions

- **BIOLOGICAL:** Allogeneic MSC infusions (IV)

## Key facts

- **NCT ID:** NCT07145502
- **Lead sponsor:** Biocells Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-19
- **Primary completion:** 2024-07-15
- **Final completion:** 2027-09-19
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145502, "Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07145502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*